Tekla Historical Financial Ratios
| HQH Stock | USD 17.38 0.13 0.75% |
Tekla Healthcare is promptly reporting on over 76 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.58 or Days Sales Outstanding of 47.03 will help investors to properly organize and evaluate Tekla Healthcare Inv financial condition quickly.
Tekla |
About Tekla Financial Ratios Analysis
Tekla Healthcare InvFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Tekla Healthcare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Tekla financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Tekla Healthcare history.
Tekla Healthcare Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Tekla Healthcare Investors dividend as a percentage of Tekla Healthcare stock price. Tekla Healthcare Inv dividend yield is a measure of Tekla Healthcare stock productivity, which can be interpreted as interest rate earned on an Tekla Healthcare investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Tekla Healthcare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Tekla Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. As of now, Tekla Healthcare's Cash Per Share is increasing as compared to previous years. The Tekla Healthcare's current Days Payables Outstanding is estimated to increase to 486.68, while Price To Sales Ratio is projected to decrease to 14.45.
| 2023 | 2024 (projected) | Payables Turnover | 1.51 | 1.43 | Days Of Inventory On Hand | 0.002387 | 0.002268 |
Tekla Healthcare fundamentals Correlations
Click cells to compare fundamentals
Tekla Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tekla Healthcare fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 3.72 | 7.24 | (4.26) | 13.23 | 15.21 | 14.45 | |
| Ptb Ratio | 0.86 | 0.98 | 0.89 | 0.83 | 0.74 | 0.58 | |
| Days Sales Outstanding | 6.17 | 9.36 | (5.44) | 43.04 | 49.5 | 47.03 | |
| Book Value Per Share | 24.04 | 26.02 | 19.36 | 18.84 | 21.66 | 22.52 | |
| Pb Ratio | 0.86 | 0.98 | 0.89 | 0.83 | 0.74 | 0.58 | |
| Ev To Sales | 3.73 | 7.31 | (4.3) | 13.23 | 15.21 | 14.45 | |
| Roic | 0.23 | 0.14 | (0.21) | (0.001273) | (0.001464) | (0.001391) | |
| Net Income Per Share | 5.5 | 3.49 | (4.1) | 1.14 | 1.31 | 2.42 | |
| Sales General And Administrative To Revenue | 0.004802 | 0.008271 | (0.007283) | 0.0213 | 0.0245 | 0.0232 | |
| Roe | 0.23 | 0.13 | (0.21) | 0.0605 | 0.0696 | 0.0754 | |
| Pe Ratio | 3.75 | 7.33 | (4.21) | 13.65 | 15.69 | 8.11 | |
| Return On Tangible Assets | 0.23 | 0.13 | (0.21) | 0.0604 | 0.0695 | 0.0754 | |
| Earnings Yield | 0.27 | 0.14 | (0.24) | 0.0733 | 0.0843 | 0.0893 | |
| Net Debt To E B I T D A | (1.3E-5) | 0.0116 | 0.0103 | 0.0702 | (0.0446) | (3.0E-6) | |
| Current Ratio | 130.82 | 0.26 | 0.3 | 34.51 | 31.06 | 16.0 | |
| Tangible Book Value Per Share | 24.04 | 26.02 | 19.36 | 18.84 | 21.66 | 22.52 | |
| Receivables Turnover | 59.13 | 38.98 | (67.05) | 8.48 | 9.75 | 9.26 | |
| Graham Number | 54.53 | 45.2 | 42.27 | 21.98 | 25.27 | 46.29 | |
| Shareholders Equity Per Share | 24.04 | 26.02 | 19.36 | 18.84 | 21.66 | 22.51 | |
| Graham Net Net | 0.74 | 0.0446 | 0.42 | 1.4 | 0.67 | 0.7 | |
| Revenue Per Share | 5.54 | 3.53 | (4.06) | 1.18 | 1.06 | 1.11 | |
| Enterprise Value Over E B I T D A | 3.73 | 7.11 | (4.34) | 13.65 | 15.69 | 16.48 | |
| Price Earnings Ratio | 3.75 | 7.33 | (4.21) | 13.65 | 15.69 | 8.11 | |
| Operating Cycle | 6.17 | 719.26 | 1.6K | 43.05 | 38.74 | 36.8 | |
| Price Book Value Ratio | 0.86 | 0.98 | 0.89 | 0.83 | 0.74 | 0.58 | |
| Price Earnings To Growth Ratio | (0.0143) | (0.2) | 0.0194 | (0.11) | (0.0961) | (0.1) | |
| Effective Tax Rate | 0.0197 | (0.008279) | (0.0403) | 0.0189 | 0.0217 | 0.0237 | |
| Return On Capital Employed | 0.23 | 0.13 | (0.21) | (0.001273) | (0.001464) | (0.001391) |
Currently Active Assets on Macroaxis
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 1.66 | Earnings Share 1.31 | Revenue Per Share 0.197 | Quarterly Revenue Growth (0.06) |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.